Among the key genetic mutations associated with T-cell lymphomas are those in the TP53 and anaplastic lymphoma kinase (ALK) genes, which significantly impact disease behavior and treatment outcomes (152). The gene discussed is ALK; the disease is T-cell non-Hodgkin lymphoma.